Since NAD(H)-dependent L-alanine dehydrogenase (EC
1.1.4.1; Ald) was identified as one of the major antigens present
in culture filtrates of Mycobacterium tuberculosis, many
studies on the enzyme have been conducted. Ald catalyzes
the reversible conversion of pyruvate to alanine with concomitant
oxidation of NADH to NAD+ and has a homohexameric
quaternary structure. Expression of the ald genes was
observed to be strongly upregulated in M. tuberculosis and
Mycobacterium smegmatis grown in the presence of alanine.
Furthermore, expression of the ald genes in some mycobacteria
was observed to increase under respiration-inhibitory
conditions such as oxygen-limiting and nutrient-starvation
conditions. Upregulation of ald expression by alanine or under
respiration-inhibitory conditions is mediated by AldR, a
member of the Lrp/AsnC family of transcriptional regulators.
Mycobacterial Alds were demonstrated to be the enzymes required
for utilization of alanine as a nitrogen source and to
help mycobacteria survive under respiration-inhibitory conditions
by maintaining cellular NADH/NAD+ homeostasis.
Several inhibitors of Ald have been developed, and their application
in combination with respiration-inhibitory antitubercular
drugs such as Q203 and bedaquiline was recently suggested.